International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 1 (January-February 2026) Submit your research before last 3 days of February to publish your research paper in the issue of January-February.

Development of a Deterministic Web Tool for Evaluation of Fixed-Dose Combinations

Author(s) Mr. Omkar Ramesh Kahane, Mr. Amit Avinash Deshmukh, Ms. Vanshita Kishor Patil, Mr. Rohak Sandip Mahajan
Country India
Abstract Fixed-dose combinations (FDCs) are widely utilised pharmaceutical products combining two or more active ingredients in a fixed ratio, developed with the aim of improving therapeutic convenience and patient adherence. However, deviations from established pharmacological principles during FDC development have resulted in formulations that lack clear evidence of benefit or introduce unnecessary safety risks. In India and other low- and middle-income countries, the prevalence of non-recommended and irrational FDCs remains substantial despite large-scale regulatory bans, reflecting gaps between policy interventions and enforcement effectiveness. Current identification of irrational FDCs is predominantly retrospective, occurring through post-marketing regulatory reviews and policy-based restrictions rather than through prospective screening at the formulation stage. This work operationalises a previously described, deterministic, rule-based pharmacological framework into an interactive web-based tool—the Predictive FDC Risk Analyzer v3.1—that provides transparent, narrative-based appraisal of mechanistic compatibility, pharmacokinetic alignment and safety overlap for two-drug combinations. The tool executes entirely within the user's browser, does not access patient-level data and explicitly restricts its intended use to educational and conceptual screening contexts without clinical validation or regulatory authority. Illustrative case examples demonstrate that the tool generates consistent, qualitative verdicts for rational, high-risk and policy-restricted combinations, reflecting the underlying rule-based logic in a transparent manner. The Analyzer serves as a structured, reproducible framework for teaching and early-stage reasoning around fixed-dose combination pharmacology, but does not provide empirical risk prediction and must not be used for clinical decision-making or regulatory submission.
Keywords Fixed‑dose combinations; Rational pharmacotherapy; Drug combinations; Pharmacological screening; Rule‑based systems; Pharmaceutical education.
Field Medical / Pharmacy
Published In Volume 8, Issue 1, January-February 2026
Published On 2026-02-04
DOI https://doi.org/10.36948/ijfmr.2026.v08i01.67906

Share this